Multiple Sclerosis (MS) and Neuroimmunology Clinical Trials
Specialists and researchers at Cedars-Sinai are constantly working to understand multiple sclerosis and leverage new diagnostic technologies and treatments. As a patient at Cedars-Sinai, you can participate in clinical trials and take advantage of these medical advancements in the diagnosis and treatment of multiple sclerosis and neuroimmunology conditions.
Questions? See the Clinical Trials FAQs.
Must be 18-65 years old; referral for a new clinical or radiological suspicion of multiple sclerosis; not on disease-modifying therapy for multiple sclerosis
The purpose of this study is to determine whether the use of an investigational magnetic resonance imaging (MRI) sequence called FLAIR* can increase the accuracy of diagnosing patients with multiple sclerosis (MS) or suspected MS.
Must be 18-60 years old; meets criteria for relapsing-remitting multiple sclerosis; must be either JC virus antibody-negative or low positive OR negative for hepatitis B and C and tuberculosis
The purpose of this study is to identify the most appropriate treatment strategy for individuals with multiple sclerosis (MS), especially shortly after diagnosis when it may be most possible to increase a patient’s chance for preventing longer-term disability.